Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$994M |
| 2 |
Cigna
CI
|
+$524M |
| 3 |
Microsoft
MSFT
|
+$395M |
| 4 |
Amazon
AMZN
|
+$281M |
| 5 |
CVS Health
CVS
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$918M |
| 2 |
AET
Aetna Inc
AET
|
+$761M |
| 3 |
PX
Praxair Inc
PX
|
+$581M |
| 4 |
COL
Rockwell Collins
COL
|
+$274M |
| 5 |
CA
CA, Inc.
CA
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.98% |
| 2 | Financials | 14.41% |
| 3 | Healthcare | 13.78% |
| 4 | Consumer Discretionary | 9.86% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAGE
3226
Niagen Bioscience
NAGE
$244M
| $1.41M | ﹤0.01% |
411,436
+5,009
| +1% | +$17.4K |
|
3227
Harvard Bioscience
HBIO
$27.6M
| $1.41M | ﹤0.01% |
44,322
+103
| +0.2% | +$4.06K |
|
|
CALA
3228
DELISTED
Calithera Biosciences, Inc
CALA
| $1.41M | ﹤0.01% |
17,548
-338
| -2% | -$33.3K |
|
3229
LG Display
LPL
$3.43B
| $1.41M | ﹤0.01% |
171,794
-229,552
| -57% | -$1.8M |
|
3230
Stagwell
STGW
$2.27B
| $1.41M | ﹤0.01% |
539,072
-19,253
| -3% | -$54.8K |
|
|
SFS
3231
DELISTED
Smart & Final Stores, Inc.
SFS
| $1.41M | ﹤0.01% |
296,938
+1,085
| +0.4% | +$5.99K |
|
|
CVIA
3232
DELISTED
Covia Holdings Corporation Common Stock
CVIA
| $1.41M | ﹤0.01% |
411,094
-38,743
| -9% | -$233K |
|
|
AGFS
3233
DELISTED
AgroFresh Solutions Inc
AGFS
| $1.4M | ﹤0.01% |
369,198
-3,185
| -0.9% | -$15.8K |
|
|
CURO
3234
DELISTED
CURO Group Holdings Corp.
CURO
| $1.4M | ﹤0.01% |
147,393
+2,066
| +1% | +$33.8K |
|
3235
Neuronetics
STIM
$222M
| $1.4M | ﹤0.01% |
72,198
-7,559
| -9% | -$166K |
|
|
FTSV
3236
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $1.4M | ﹤0.01% |
88,769
+70,591
| +388% | +$1.08M |
|
|
AUY
3237
DELISTED
Yamana Gold, Inc.
AUY
| $1.4M | ﹤0.01% |
591,214
-67,709
| -10% | -$158K |
|
|
AMJ
3238
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $1.39M | ﹤0.01% |
62,454
+53,395
| +589% | +$1.35M |
|
|
VRN
3239
DELISTED
Veren
VRN
| $1.39M | ﹤0.01% |
460,368
+25,039
| +6% | +$107K |
|
3240
Pulse Biosciences
PLSE
$3.17B
| $1.39M | ﹤0.01% |
121,031
+11,212
| +10% | +$136K |
|
3241
Rockwell Medical
RMTI
$27.9M
| $1.39M | ﹤0.01% |
5,578
-185
| -3% | -$73.6K |
|
3242
Turkcell
TKC
$4.72B
| $1.39M | ﹤0.01% |
246,443
+31,681
| +15% | +$169K |
|
3243
Escalade
ESCA
$286M
| $1.39M | ﹤0.01% |
120,964
-697
| -0.6% | -$8.24K |
|
|
IEA
3244
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $1.38M | ﹤0.01% |
168,571
-1,504
| -0.9% | -$13.8K |
|
3245
Globalstar
GSAT
$10.8B
| $1.38M | ﹤0.01% |
143,641
+4,038
| +3% | +$24.1K |
|
|
KG
3246
Kestrel Group
KG
$68.8M
| $1.38M | ﹤0.01% |
41,669
+220
| +0.5% | +$11.8K |
|
3247
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.6B
| $1.37M | ﹤0.01% |
1,217,317
+28,354
| +2% | +$3.19M |
|
3248
iShares S&P Small-Cap 600 Value ETF
IJS
$8.33B
| $1.37M | ﹤0.01% |
20,804
+1,424
| +7% | +$106K |
|
|
MBCN
3249
DELISTED
Middlefield Banc Corp
MBCN
| $1.37M | ﹤0.01% |
64,648
-2,452
| -4% | -$55K |
|
3250
Siebert Financial
SIEB
$68.8M
| $1.37M | ﹤0.01% |
94,698
| – | – |
|
Similar funds
Northern Trust's Q4 2018 Portfolio in Review
As of Q4 2018, Northern Trust held 4,401 positions worth $357B, down 13% from $409B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 5%. Northern Trust opened 95 new positions and exited 125, leaving the 4,401-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2018 buy was Linde: 6,288,266 shares worth $981M.
- Northern Trust added most to Cigna in Q4 2018, an estimated $524M increase.
- Northern Trust's biggest Q4 2018 reduction was FlexShares iBoxx 3-Year Target Duration TIPS Index Fund, cutting an estimated $224M.
- Northern Trust fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $918M.
- Northern Trust's ten largest holdings make up 16% of its $357B portfolio in Q4 2018.
- Northern Trust opened 95 new positions and closed 125 in Q4 2018.
- Northern Trust's portfolio value fell 13% quarter-over-quarter to $357B.
Based on Northern Trust's 13F filing for Q4 2018, filed 12 Feb 2019.